These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The Streptococcus milleri group--an unrecognized cause of disease in cystic fibrosis: a case series and literature review. Parkins MD; Sibley CD; Surette MG; Rabin HR Pediatr Pulmonol; 2008 May; 43(5):490-7. PubMed ID: 18383109 [TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa Can Inhibit Growth of Streptococcal Species via Siderophore Production. Scott JE; Li K; Filkins LM; Zhu B; Kuchma SL; Schwartzman JD; O'Toole GA J Bacteriol; 2019 Apr; 201(8):. PubMed ID: 30718303 [TBL] [Abstract][Full Text] [Related]
11. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960 [TBL] [Abstract][Full Text] [Related]
12. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience. Stressmann FA; Rogers GB; van der Gast CJ; Marsh P; Vermeer LS; Carroll MP; Hoffman L; Daniels TW; Patel N; Forbes B; Bruce KD Thorax; 2012 Oct; 67(10):867-73. PubMed ID: 22707521 [TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis. Reid DW; Latham R; Lamont IL; Camara M; Roddam LF J Cyst Fibros; 2013 Dec; 12(6):688-99. PubMed ID: 23706827 [TBL] [Abstract][Full Text] [Related]